AHCO
AdaptHealth Corp.
Price Chart
Latest Quote
$9.89
| Previous Close | $9.73 |
| Open | $9.83 |
| Day High | $10.07 |
| Day Low | $9.76 |
| Volume | 920,380 |
Stock Information
| Shares Outstanding | 136.05M |
| Total Debt | $2.00B |
| Cash Equivalents | $47.96M |
| Revenue | $3.29B |
| Net Income | $-79.63M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $1.35B |
| EPS (TTM) | $-0.59 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $3.28B |
| Sales | $3.29B |
| Income | $-79.63M |
| Book/sh | $11.32 |
| Cash/sh | $0.35 |
| Employees | 11K |
Financial Ratios
| Quick Ratio | 0.61 |
| Current Ratio | 0.93 |
| Debt/Eq | 132.10 |
Returns & Margins
| ROA | 2.64% |
| ROE | -4.85% |
| Gross Margin | 20.40% |
| Operating Margin | 0.67% |
| Profit Margin | -2.42% |
Ownership
| Insider Ownership | 8.06% |
| Institutional Ownership | 106.67% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 8.41 |
| P/S | 0.41 |
| P/B | 0.87 |
Analyst Data
| Recommendation | buy |
| Target Price | $14.00 |
Technical Indicators
| SMA20 | $10.43 |
| SMA50 | $11.57 |
| SMA200 | $10.17 |
| RSI | 27.75 |
| ATR | 0.3429 |
| Shares Float | 85.69M |
| Short Float | 6.98% |
| Short Ratio | 4.55 |
| Volatility | 1.46 |
| Rel Volume | 0.69 |
Performance History
| Week | -2.37% |
| Month | -13.40% |
| Quarter | +4.21% |
| 6 Months | +5.89% |
| YTD | +2.28% |
| Year | +11.63% |
| 3 Years | -5.63% |
| 5 Years | -62.24% |
| 10 Years | +1.96% |
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-05 | $9.89 | 920,400 |
| 2026-06-04 | $9.73 | 1,245,700 |
| 2026-06-03 | $9.72 | 1,526,300 |
| 2026-06-02 | $9.65 | 1,798,200 |
| 2026-06-01 | $9.93 | 1,944,300 |
| 2026-05-29 | $10.13 | 1,451,900 |
| 2026-05-28 | $10.35 | 1,503,700 |
| 2026-05-27 | $10.36 | 825,800 |
| 2026-05-26 | $10.36 | 826,700 |
| 2026-05-22 | $10.45 | 730,700 |
| 2026-05-21 | $10.53 | 755,200 |
| 2026-05-20 | $10.48 | 1,101,700 |
| 2026-05-19 | $10.35 | 1,387,500 |
| 2026-05-18 | $10.72 | 1,342,000 |
| 2026-05-15 | $10.66 | 1,130,700 |
| 2026-05-14 | $10.74 | 1,247,200 |
| 2026-05-13 | $10.81 | 1,863,500 |
| 2026-05-12 | $11.25 | 1,869,400 |
| 2026-05-11 | $11.24 | 1,838,500 |
| 2026-05-08 | $11.30 | 1,484,500 |
| 2026-05-07 | $11.73 | 1,953,000 |
| 2026-05-06 | $11.42 | 2,346,100 |
About AdaptHealth Corp.
AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments. The company offers sleep therapy equipment, supplies, and related services, such as continuous positive airway pressure and BiLevel services to individuals suffering from obstructive sleep apnea; oxygen and home mechanical ventilation equipment and supplies and related chronic therapy services; and medical devices, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; and other HME devices and supplies. It also provides PAP machines, wheelchairs, hospital beds, oxygen concentrators, ventilators, insulin pumps, diabetes management and wound care supplies, orthopedic bracing, breast pumps and supplies, walkers, commodes, enteral supplies, and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Conshohocken, Pennsylvania.
đ° Latest News
1 Cash-Producing Stock with Impressive Fundamentals and 2 We Brush Off
StockStory âĸ 2026-06-04T22:05:30ZRepligen, AdaptHealth, and IQVIA Stocks Trade Down, What You Need To Know
StockStory âĸ 2026-05-17T09:56:55ZThe Top 5 Analyst Questions From AdaptHealthâs Q1 Earnings Call
StockStory âĸ 2026-05-15T14:20:55ZConsumer Sentiment Just Crashed Below the Recession Threshold. These 3 Defensive Stocks Under $25 Are Built for What Comes Next
24/7 Wall St. âĸ 2026-05-14T15:47:14ZCanaccord Lifts PT on AdaptHealth Corp. (AHCO) Following Q1 Results
Insider Monkey âĸ 2026-05-12T21:28:38ZAdaptHealth Conference: Kaiser Deal Drives Growth, Labor Costs Dent EBITDA
MarketBeat âĸ 2026-05-12T18:12:26ZSenior Health, Home Health & Hospice Stocks Q1 Highlights: AdaptHealth (NASDAQ:AHCO)
StockStory âĸ 2026-05-12T11:56:55ZAdaptHealth's Labor Headwinds Lead to Fast Onboarding of Capitated Contract, RBC Says
MT Newswires âĸ 2026-05-11T16:00:55ZA Look At AdaptHealth (AHCO) Valuation As Investor Interest And Price Targets Diverge
Simply Wall St. âĸ 2026-05-09T20:13:10ZAdaptHealth (AHCO) Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-05-06T13:28:00ZIncome Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $2,294,371,000 | $2,259,593,000 | $2,250,414,000 | $2,104,192,000 |
| Cost Of Revenue | $2,635,658,000 | $2,579,882,000 | $2,576,110,000 | $2,390,480,000 |
| Total Revenue | $3,244,857,000 | $3,260,975,000 | $3,200,177,000 | $2,970,595,000 |
| Operating Revenue | $3,244,857,000 | $3,260,975,000 | $3,200,177,000 | $2,970,595,000 |
| Expenses | ||||
| Interest Expense | $105,753,000 | $126,668,000 | $130,299,000 | $109,414,000 |
| Total Expenses | $3,058,591,000 | $2,984,165,000 | $2,967,791,000 | $2,780,184,000 |
| Rent Expense Supplemental | $74,391,000 | $71,874,000 | $68,375,000 | $65,979,000 |
| Other Income Expense | $-95,667,000 | $-14,123,000 | $-825,871,000 | $16,905,000 |
| Other Non Operating Income Expenses | $-274,000 | $-2,793,000 | $-29,566,000 | $-253,000 |
| Net Non Operating Interest Income Expense | $-105,753,000 | $-126,668,000 | $-130,299,000 | $-109,414,000 |
| Interest Expense Non Operating | $105,753,000 | $126,668,000 | $130,299,000 | $109,414,000 |
| Operating Expense | $422,933,000 | $404,283,000 | $391,681,000 | $389,704,000 |
| General And Administrative Expense | $382,293,000 | $359,238,000 | $334,594,000 | $324,814,000 |
| Other Operating Expenses | - | - | - | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-70,794,000 | $90,422,000 | $-678,895,000 | $69,316,000 |
| Net Interest Income | $-105,753,000 | $-126,668,000 | $-130,299,000 | $-109,414,000 |
| Normalized Income | $4,566,470 | $98,319,010 | $63,261,260 | $56,498,974 |
| Net Income From Continuing And Discontinued Operation | $-70,794,000 | $90,422,000 | $-678,895,000 | $69,316,000 |
| Total Operating Income As Reported | $90,873,000 | $263,732,000 | $-598,401,000 | $190,411,000 |
| Average Dilution Earnings | $0 | $0 | $-34,482,000 | $-17,158,000 |
| Net Income Common Stockholders | $-70,794,000 | $82,747,000 | $-678,895,000 | $63,449,000 |
| Net Income | $-70,794,000 | $90,422,000 | $-678,895,000 | $69,316,000 |
| Net Income Including Noncontrolling Interests | $-66,038,000 | $94,780,000 | $-674,780,000 | $73,133,000 |
| Net Income Continuous Operations | $-66,038,000 | $94,780,000 | $-674,780,000 | $73,133,000 |
| Pretax Income | $-15,154,000 | $136,019,000 | $-723,784,000 | $97,902,000 |
| Special Income Charges | $-95,393,000 | $-15,351,000 | $-830,787,000 | $0 |
| Operating Income | $186,266,000 | $276,810,000 | $232,386,000 | $190,411,000 |
| Depreciation Amortization Depletion Income Statement | $40,640,000 | $45,045,000 | $57,087,000 | $64,890,000 |
| Depreciation And Amortization In Income Statement | $40,640,000 | $45,045,000 | $57,087,000 | $64,890,000 |
| Gross Profit | $609,199,000 | $681,093,000 | $624,067,000 | $580,115,000 |
| Per Share | ||||
| Diluted EPS | $-0.52 | $0.61 | $-5.31 | $0.33 |
| Basic EPS | $-0.52 | $0.62 | $-5.06 | $0.47 |
| Other | ||||
| Tax Effect Of Unusual Items | $-20,032,530 | $-3,432,990 | $-54,148,740 | $4,340,974 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $567,919,000 | $639,351,000 | $585,603,000 | $541,336,000 |
| Total Unusual Items | $-95,393,000 | $-11,330,000 | $-796,305,000 | $17,158,000 |
| Total Unusual Items Excluding Goodwill | $-95,393,000 | $-11,330,000 | $-796,305,000 | $17,158,000 |
| Reconciled Depreciation | $381,927,000 | $365,334,000 | $382,783,000 | $351,178,000 |
| EBITDA (Bullshit earnings) | $472,526,000 | $628,021,000 | $-210,702,000 | $558,494,000 |
| EBIT | $90,599,000 | $262,687,000 | $-593,485,000 | $207,316,000 |
| Diluted Average Shares | $135,146,000 | $135,531,000 | $134,418,000 | $138,988,000 |
| Basic Average Shares | $135,146,000 | $133,756,000 | $134,156,000 | $134,175,000 |
| Diluted NI Availto Com Stockholders | $-70,794,000 | $82,747,000 | $-713,377,000 | $46,291,000 |
| Minority Interests | $-4,756,000 | $-4,358,000 | $-4,115,000 | $-3,817,000 |
| Tax Provision | $50,884,000 | $41,239,000 | $-49,004,000 | $24,769,000 |
| Gain On Sale Of Business | $32,602,000 | $0 | $0 | - |
| Impairment Of Capital Assets | $127,995,000 | $13,078,000 | $830,787,000 | $0 |
| Selling General And Administration | $382,293,000 | $359,238,000 | $334,594,000 | $324,814,000 |
| Other Gand A | $382,293,000 | $359,238,000 | $334,594,000 | $324,814,000 |
| Preferred Stock Dividends | - | $7,675,000 | - | $5,867,000 |
| Other Special Charges | - | $2,273,000 | - | - |
| Gain On Sale Of Security | - | $4,021,000 | $34,482,000 | $17,158,000 |
| Otherunder Preferred Stock Dividend | - | - | $0 | $5,867,000 |
| Restructuring And Mergern Acquisition | - | - | $0 | $0 |
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-1,107,987,000 | $-1,209,569,000 | $-1,396,664,000 | $-1,556,912,000 |
| Total Assets | $4,316,577,000 | $4,486,947,000 | $4,508,650,000 | $5,219,587,000 |
| Total Non Current Assets | $3,587,678,000 | $3,731,159,000 | $3,859,628,000 | $4,634,279,000 |
| Other Non Current Assets | $19,119,000 | $17,584,000 | $21,128,000 | $22,415,000 |
| Non Current Deferred Assets | $267,786,000 | $314,505,000 | $345,854,000 | $281,786,000 |
| Non Current Deferred Taxes Assets | $267,786,000 | $314,505,000 | $345,854,000 | $281,786,000 |
| Goodwill And Other Intangible Assets | $2,626,549,000 | $2,780,714,000 | $2,855,118,000 | $3,708,070,000 |
| Other Intangible Assets | $85,121,000 | $105,548,000 | $130,160,000 | $162,773,000 |
| Current Assets | $728,899,000 | $755,788,000 | $649,022,000 | $585,308,000 |
| Other Current Assets | $100,619,000 | $45,432,000 | $69,338,000 | $52,136,000 |
| Assets Held For Sale Current | $0 | $52,748,000 | $0 | - |
| Inventory | $151,247,000 | $139,842,000 | $113,642,000 | $127,754,000 |
| Receivables | $370,897,000 | $408,019,000 | $388,910,000 | $359,146,000 |
| Accounts Receivable | $370,897,000 | $408,019,000 | $388,910,000 | $359,146,000 |
| Cash Cash Equivalents And Short Term Investments | $106,136,000 | $109,747,000 | $77,132,000 | $46,272,000 |
| Cash And Cash Equivalents | $106,136,000 | $109,747,000 | $77,132,000 | $46,272,000 |
| Cash Financial | $106,136,000 | $109,747,000 | - | $46,272,000 |
| Cash Equivalents | - | - | - | $0 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Net Debt | $1,630,160,000 | $1,871,424,000 | $2,070,850,000 | $2,141,995,000 |
| Total Debt | $1,902,800,000 | $2,130,336,000 | $2,294,649,000 | $2,328,823,000 |
| Long Term Debt And Capital Lease Obligation | $1,834,057,000 | $2,069,826,000 | $2,202,889,000 | $2,261,611,000 |
| Long Term Debt | $1,715,983,000 | $1,964,921,000 | $2,094,614,000 | $2,153,267,000 |
| Current Debt And Capital Lease Obligation | $68,743,000 | $60,510,000 | $91,760,000 | $67,212,000 |
| Current Debt | $20,313,000 | $16,250,000 | $53,368,000 | $35,000,000 |
| Other Current Borrowings | $20,313,000 | $16,250,000 | $53,368,000 | $35,000,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $2,790,253,000 | $2,908,829,000 | $3,041,981,000 | $3,061,829,000 |
| Total Non Current Liabilities Net Minority Interest | $2,077,861,000 | $2,341,842,000 | $2,504,982,000 | $2,605,615,000 |
| Other Non Current Liabilities | $243,804,000 | $272,016,000 | $302,093,000 | $305,501,000 |
| Current Liabilities | $712,392,000 | $566,987,000 | $536,999,000 | $456,214,000 |
| Other Current Liabilities | $30,106,000 | $33,548,000 | $14,675,000 | $19,863,000 |
| Current Deferred Liabilities | $59,843,000 | $34,944,000 | $38,570,000 | $31,641,000 |
| Payables And Accrued Expenses | $503,900,000 | $435,235,000 | $391,994,000 | $337,498,000 |
| Interest Payable | $28,447,000 | $28,818,000 | $29,327,000 | $28,877,000 |
| Payables | $352,381,000 | $281,852,000 | $268,844,000 | $222,505,000 |
| Accounts Payable | $352,381,000 | $281,852,000 | $211,504,000 | $222,505,000 |
| Derivative Product Liabilities | - | - | $0 | $38,503,000 |
| Other Payable | - | - | $57,340,000 | $44,244,000 |
| Equity | ||||
| Common Stock Equity | $1,518,561,000 | $1,571,144,000 | $1,458,453,000 | $2,151,157,000 |
| Preferred Stock Equity | $1,000 | $1,000 | $1,000 | $1,000 |
| Total Equity Gross Minority Interest | $1,526,324,000 | $1,578,118,000 | $1,466,669,000 | $2,157,758,000 |
| Stockholders Equity | $1,518,562,000 | $1,571,145,000 | $1,458,454,000 | $2,151,158,000 |
| Gains Losses Not Affecting Retained Earnings | $78,000 | $2,253,000 | $4,356,000 | $8,693,000 |
| Other Equity Adjustments | $78,000 | $2,253,000 | $4,356,000 | $8,693,000 |
| Retained Earnings | $-632,972,000 | $-562,178,000 | $-652,600,000 | $26,295,000 |
| Other | ||||
| Treasury Shares Number | $2,935,035 | $2,935,035 | $3,935,035 | $750,835 |
| Ordinary Shares Number | $132,515,329 | $134,602,317 | $132,634,850 | $134,435,119 |
| Share Issued | $135,450,364 | $137,537,352 | $136,569,885 | $135,185,954 |
| Tangible Book Value | $-1,107,988,000 | $-1,209,570,000 | $-1,396,665,000 | $-1,556,913,000 |
| Invested Capital | $3,254,857,000 | $3,552,315,000 | $3,606,435,000 | $4,339,424,000 |
| Working Capital | $16,507,000 | $188,801,000 | $112,023,000 | $129,094,000 |
| Capital Lease Obligations | $166,504,000 | $149,165,000 | $146,667,000 | $140,556,000 |
| Total Capitalization | $3,234,545,000 | $3,536,066,000 | $3,553,068,000 | $4,304,425,000 |
| Minority Interest | $7,762,000 | $6,973,000 | $8,215,000 | $6,600,000 |
| Treasury Stock | $25,548,000 | $25,548,000 | $43,267,000 | $13,992,000 |
| Additional Paid In Capital | $2,176,990,000 | $2,156,604,000 | $2,149,951,000 | $2,130,148,000 |
| Capital Stock | $14,000 | $14,000 | $14,000 | $14,000 |
| Common Stock | $13,000 | $13,000 | $13,000 | $13,000 |
| Preferred Stock | $1,000 | $1,000 | $1,000 | $1,000 |
| Long Term Capital Lease Obligation | $118,074,000 | $104,905,000 | $108,275,000 | $108,344,000 |
| Current Deferred Revenue | $59,843,000 | $34,944,000 | $38,570,000 | $31,641,000 |
| Current Capital Lease Obligation | $48,430,000 | $44,260,000 | $38,392,000 | $32,212,000 |
| Current Provisions | $49,800,000 | $2,750,000 | - | - |
| Current Accrued Expenses | $151,519,000 | $153,383,000 | $123,150,000 | $114,993,000 |
| Goodwill | $2,541,428,000 | $2,675,166,000 | $2,724,958,000 | $3,545,297,000 |
| Net PPE | $674,224,000 | $618,356,000 | $637,528,000 | $622,008,000 |
| Accumulated Depreciation | $-524,148,000 | $-518,176,000 | $-436,981,000 | $-383,188,000 |
| Gross PPE | $1,198,372,000 | $1,136,532,000 | $1,074,509,000 | $1,005,196,000 |
| Other Properties | $1,111,697,000 | $1,010,231,000 | $953,979,000 | $898,973,000 |
| Machinery Furniture Equipment | $86,675,000 | $126,301,000 | $120,530,000 | $106,223,000 |
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $219,383,000 | $235,784,000 | $143,203,000 | $-17,556,000 |
| Operating Activities | ||||
| Operating Cash Flow | $601,771,000 | $541,839,000 | $480,666,000 | $373,867,000 |
| Cash Flow From Continuing Operating Activities | $601,771,000 | $541,839,000 | $480,666,000 | $373,867,000 |
| Operating Gains Losses | $-32,602,000 | $-2,115,000 | $-36,283,000 | $-20,094,000 |
| Investing Activities | ||||
| Capital Expenditure | $-382,388,000 | $-306,055,000 | $-337,463,000 | $-391,423,000 |
| Investing Cash Flow | $-303,190,000 | $-310,275,000 | $-357,278,000 | $-411,171,000 |
| Cash Flow From Continuing Investing Activities | $-303,190,000 | $-310,275,000 | $-357,278,000 | $-411,171,000 |
| Net Other Investing Changes | $1,156,000 | $5,316,000 | - | - |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $0 | $0 | $-29,275,000 | $-13,992,000 |
| Financing Cash Flow | $-302,192,000 | $-198,949,000 | $-92,528,000 | $-66,051,000 |
| Cash Flow From Continuing Financing Activities | $-302,192,000 | $-198,949,000 | $-92,528,000 | $-66,051,000 |
| Net Other Financing Charges | $-34,925,000 | $-20,825,000 | $-14,102,000 | $-20,009,000 |
| Net Common Stock Issuance | $0 | $0 | $-29,275,000 | $-13,992,000 |
| Issuance Of Capital Stock | - | - | $0 | $0 |
| Common Stock Issuance | - | - | $0 | $0 |
| Cash Dividends Paid | - | - | - | - |
| Other | ||||
| Repayment Of Debt | $-268,478,000 | $-433,342,000 | $-101,769,000 | $-36,176,000 |
| Issuance Of Debt | $0 | $253,477,000 | $50,000,000 | $0 |
| Interest Paid Supplemental Data | $101,243,000 | $122,072,000 | $126,228,000 | $108,885,000 |
| Income Tax Paid Supplemental Data | $24,283,000 | $14,139,000 | $14,756,000 | $14,949,000 |
| End Cash Position | $106,136,000 | $109,747,000 | $77,132,000 | $46,272,000 |
| Beginning Cash Position | $109,747,000 | $77,132,000 | $46,272,000 | $149,627,000 |
| Changes In Cash | $-3,611,000 | $32,615,000 | $30,860,000 | $-103,355,000 |
| Proceeds From Stock Option Exercised | $1,211,000 | $1,741,000 | $2,618,000 | $4,126,000 |
| Common Stock Payments | $0 | $0 | $-29,275,000 | $-13,992,000 |
| Net Issuance Payments Of Debt | $-268,478,000 | $-179,865,000 | $-51,769,000 | $-36,176,000 |
| Net Long Term Debt Issuance | $-268,478,000 | $-179,865,000 | $-51,769,000 | $-36,176,000 |
| Long Term Debt Payments | $-268,478,000 | $-433,342,000 | $-101,769,000 | $-36,176,000 |
| Long Term Debt Issuance | $0 | $253,477,000 | $50,000,000 | $0 |
| Net Investment Purchase And Sale | $0 | $0 | $-128,000 | $-731,000 |
| Purchase Of Investment | $0 | $0 | $-128,000 | $-731,000 |
| Net Business Purchase And Sale | $78,042,000 | $-9,536,000 | $-19,687,000 | $-19,017,000 |
| Sale Of Business | $120,420,000 | $0 | $0 | - |
| Purchase Of Business | $-42,378,000 | $-9,536,000 | $-19,687,000 | $-19,017,000 |
| Net PPE Purchase And Sale | $-382,388,000 | $-306,055,000 | $-337,463,000 | $-391,423,000 |
| Purchase Of PPE | $-382,388,000 | $-306,055,000 | $-337,463,000 | $-391,423,000 |
| Change In Working Capital | $66,579,000 | $-26,059,000 | $-25,109,000 | $-107,996,000 |
| Change In Other Current Liabilities | $108,155,000 | $898,000 | $8,527,000 | $-88,344,000 |
| Change In Prepaid Assets | $-61,071,000 | $27,325,000 | $-20,305,000 | $-13,143,000 |
| Change In Inventory | $-11,491,000 | $-28,065,000 | $15,531,000 | $-6,300,000 |
| Change In Receivables | $30,986,000 | $-26,217,000 | $-28,862,000 | $-209,000 |
| Changes In Account Receivables | $30,986,000 | $-26,217,000 | $-28,862,000 | $-209,000 |
| Other Non Cash Items | $54,871,000 | $49,892,000 | $43,395,000 | $37,213,000 |
| Stock Based Compensation | $21,876,000 | $14,880,000 | $22,468,000 | $22,397,000 |
| Asset Impairment Charge | $127,995,000 | $13,078,000 | $830,787,000 | $0 |
| Deferred Tax | $47,163,000 | $32,049,000 | $-62,595,000 | $18,036,000 |
| Deferred Income Tax | $47,163,000 | $32,049,000 | $-62,595,000 | $18,036,000 |
| Depreciation Amortization Depletion | $381,927,000 | $365,334,000 | $382,783,000 | $351,178,000 |
| Depreciation And Amortization | $381,927,000 | $365,334,000 | $382,783,000 | $351,178,000 |
| Gain Loss On Sale Of Business | $-32,602,000 | $0 | $0 | - |
| Net Income From Continuing Operations | $-66,038,000 | $94,780,000 | $-674,780,000 | $73,133,000 |
| Gain Loss On Investment Securities | - | $-4,388,000 | $-36,283,000 | $-20,094,000 |
| Sale Of Investment | - | - | - | $0 |
| Change In Other Working Capital | - | - | - | $-31,213,000 |